Skip to main content

Sanofi Consumer Healthcare India Ltd

NSE: SANOFICONR BSE: 544250Pharma

Incorporated in 2023, Sanofi Consumer Healthcare India Ltd manufactures and trading of drugs & pharmaceutical products.[1]It is a division of Sanofi, a global pharmaceutical company, focusing on over-the-counter (OTC) and consumer healthcare products. [2]

4,795
52W: ₹3950 — ₹5954
PE 43.7 · Book ₹167 · +2771% vs book
Market Cap₹11,044 Cr
Stock P/E43.7Price to Earnings
ROCE108%Return on Capital
ROE86.2%Return on Equity
Div. Yield1.13%Face Value ₹10

Strengths

  • +Company is almost debt free.
  • +Company is expected to give good quarter
  • +Company has a good return on equity (ROE) track record: 3 Years ROE 83.6%

Weaknesses

  • Stock is trading at 28.7 times its book value

Shareholding Pattern

Promoters71.27%
FIIs2.76%
DIIs17.57%
Public8.41%
CategoryJun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Promoters60.4%60.4%60.4%60.4%71.27%10.971.27%71.27%71.27%
FIIs6.03%5.22%0.84.42%0.84.52%0.13.24%1.32.94%0.32.83%0.12.76%0.1
DIIs22.6%23.83%1.225.35%1.525.48%0.116.89%8.617.21%0.317.33%0.117.57%0.2
Public10.98%10.56%0.49.84%0.79.59%0.38.59%1.08.58%0.08.57%0.08.41%0.2

Financial Statements

MetricDec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Sales225222172160171173221234251229
Expenses13514010997109109151149161140
Operating Profit90826463626470859089
OPM %40%37%37%39%36%37%32%36%36%39%
Net Profit68632945445061636668
EPS ₹0012.5919.5419.2421.7126.3627.3128.8729.44

AI Insights

Revenue Trend

TTM revenue at ₹935Cr, up 6.5% YoY. OPM at 36%.

Debt Position

Borrowings at ₹28Cr. Debt-to-equity ratio: 0.12x. Healthy balance sheet.

Institutional Flow

DIIs: 17.57% (-5.03pp change). FIIs: 2.76% (-3.27pp change). Promoters hold 71.27%.

Margin & Efficiency

ROCE improving from 0% (Dec 2023) to 0% (Dec 2025). Working capital days: 0.

Valuation

PE 43.7x with 108% ROCE. Price is 2771% above book value of ₹167. Dividend yield: 1.13%.

Recent Announcements